The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
87857896 8785789 6 F 20120713 20160823 20120914 20160826 EXP JP-GLAXOSMITHKLINE-B0826789A GLAXOSMITHKLINE MASAYASU YAMAGUCHI, ET AL.. TWO CASES OF SEVERE DRUG ERUPTION CAUSED BY LAMOTRIGINE. 2013;S:386 64.91 YR F Y 35.00000 KG 20160826 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
87857896 8785789 1 PS LAMOTRIGINE. LAMOTRIGINE 1 Oral Y U 20241 50 MG TABLET QD
87857896 8785789 2 SS LAMOTRIGINE. LAMOTRIGINE 1 Oral Y U 20241 50 MG TABLET BID
87857896 8785789 3 SS LAMOTRIGINE. LAMOTRIGINE 1 Oral Y U 20241 100 MG TABLET BID
87857896 8785789 4 SS TEGRETOL CARBAMAZEPINE 1 Oral 100 MG, TID 60000 MG Y U 0 100 MG TID
87857896 8785789 5 SS TEGRETOL CARBAMAZEPINE 1 Oral 200 MG, U 60000 MG Y U 0 200 MG
87857896 8785789 6 SS TEGRETOL CARBAMAZEPINE 1 Oral 100 MG, QD 60000 MG Y U 0 100 MG QD
87857896 8785789 7 C ZYPREXA OLANZAPINE 1 Oral U 0 5 MG TABLET QD
87857896 8785789 8 C Jzoloft SERTRALINE HYDROCHLORIDE 1 Oral U 0 100 MG TABLET QD
87857896 8785789 9 C Meilax ETHYL LOFLAZEPATE 1 Oral U 0 1 MG ORAL DRUG UNSPECIFIED FORM QD
87857896 8785789 10 C Pursennid SENNOSIDES A AND B 1 Oral U 0 24 MG TABLET QD
87857896 8785789 11 C Metligine D 2 Oral U 0 2 MG TABLET BID
87857896 8785789 12 C URALYT POTASSIUM CITRATETRISODIUM CITRATE DIHYDRATE 1 3 DF, TID 0 3 DF TID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
87857896 8785789 1 Bipolar II disorder
87857896 8785789 4 Bipolar II disorder
87857896 8785789 7 Bipolar II disorder
87857896 8785789 8 Depression
87857896 8785789 9 Anxiety
87857896 8785789 10 Constipation
87857896 8785789 11 Orthostatic hypotension

Outcome of event

Event ID CASEID OUTC COD
87857896 8785789 HO
87857896 8785789 LT
87857896 8785789 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
87857896 8785789 Drug eruption
87857896 8785789 Erythema
87857896 8785789 Mouth haemorrhage
87857896 8785789 Oculomucocutaneous syndrome
87857896 8785789 Oral mucosa erosion
87857896 8785789 Rash
87857896 8785789 Stevens-Johnson syndrome
87857896 8785789 Stomatitis
87857896 8785789 Toxic epidermal necrolysis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
87857896 8785789 1 20120612 20120625 0
87857896 8785789 2 20120626 20120709 0
87857896 8785789 3 20120710 20120716 0
87857896 8785789 4 20111208 20120625 0
87857896 8785789 5 20120626 20120712 0
87857896 8785789 6 20120713 20120716 0
87857896 8785789 7 20120302 0
87857896 8785789 8 20111208 20120820 0
87857896 8785789 9 20111208 20120806 0
87857896 8785789 10 20111215 0
87857896 8785789 11 20111208 0